Phenotypic shift of astrocytes from A1 to A2 induced by fasudil improves demyelination recovery in cuprizone-treated mice
FSD is identified as a promising therapeutic candidate for inhibiting demyelination through the regulation of AST polarization via specific signaling mechanism and ameliorated CPZ-induced demyelination.